This is the authors' abstract. We don't add key points for this paper.
• Nanogel carriers can protect proteins from degradation and provide controlled release. • This work developed redox-responsive nanogels for targeted intracellular protein delivery. • Redox-responsive nanogels were successfully developed for targeted intracellular protein delivery. • Precision protein release inside cells was achieved via incorporation of disulfide crosslinkers. • These nanocarriers have promising applications for enhanced efficacy of protein therapeutics. Redox-responsive drug carriers present a therapeutically viable delivery platform owing to their ability to leverage the intracellular redox environment. In this work, we describe a facile, one-pot aqueous-based synthetic methodology for encapsulating sensitive biological payloads within redox-responsive crosslinked nanogels. We systematically evaluate the impact of various disulphide-based crosslinkers on the morphology, stability, encapsulation and loading capacities of these nanogels. In vitro assessments were conducted to elucidate the ease of delivery of functional protein payloads, using fluorescently-labelled bovine serum albumin and the enzyme, paraoxonase-1. The nanogels demonstrate promising delivery efficiencies with minimal cytotoxicity in vitro . The simplicity of their synthesis, along with the precise control achieved in nanogel degradation and payload release kinetics, not only enriches our understanding of redox-responsive nanosystems but also underscores their potential to catalyze transformative advancements in intracellular protein delivery.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Dabas et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: